The Jamboxx is a unique input device that uses the player's breath as a controller. Jamboxx: Breathe Easy is a suite of minigames played using inhalation as a control with a digital spirometer; encouraging patients to use their devices and speed up their recovery! This is an STTR grant which utilizes the Jamboxx for respiratory therapy.

1. Group 1 - Spinal Cord Injury Patients for Long Term Evaluation: This group includes quadriplegic and other spinal cord injury outpatients, with the software aimed at long-term reuse to exercise and develop respiratory ability. The proposed approach would monitor 50 patients over the span of 1 year. The desired outcome is that patients using the software and device show greater improvement in respiratory ability and a lowered rate of adverse effects. A portion of the patients will be used as a control group, given the standard (non-respiratory) Jamboxx device and software. The target audience is expected to be adult patients.
2. Group 2 - Children with Cystic Fibrosis for Long Term Evaluation: The software for this group would focus on training users in a sequential breathing technique vital for autogenic drainage (something that has previously been "impossible" within the target age group). The proposed approach would monitor 50 patients over the span of 6 months. The desired outcome is that the patients are shown to be able to comply with the autogenic drainage technique after using the software and hardware over a period of time. There is no control group planned. The patients are predicted to be around 6 - 12 years old.
3. Group 3 - Post-Op Inpatients for Short Term Evaluation: The software acts as an entertaining and replayable "skin" or presentation to the established spirometry testing protocol. The proposed approach would monitor 190 patients over the span of 72 hours or less each. The desired outcome is that patients using the software and hardware are shown to be more rigorous in performing their spirometry exercises, and in general show greater improvement in respiratory function by the end of the testing period. A portion of the patients will be used as a control group, given standard incentive spirometer devices. These patients are predicted to be older adults from the ages of 50 - 65 years old.